ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)

CUSIP: 682310875

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, no par value
Shares outstanding
109,272,143
Total 13F shares
1,085,633
Share change
+285,239
Total reported value
$2,586,529
Price per share
$2.38
Number of holders
30
Value change
+$776,286
Number of buys
13
Number of sells
7

Security key

682310875

Report period

Q4 2020

Institutions

30

Top holders

10

Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Creative Planning
13F
Company
0.16%
170,000
$287,000 30 Sep 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.11%
122,000
$206,000 30 Sep 2020
13F
WEDBUSH SECURITIES INC
13F
Company
0.1%
111,600
$189,000 30 Sep 2020
13F
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC
13F
Company
0.09%
93,411
$158,000 30 Sep 2020
13F
CIBC WORLD MARKET INC.
13F
Company
0.06%
60,688
$103,000 30 Sep 2020
13F
ROYAL BANK OF CANADA
13F
Company
0.03%
30,619
$52,000 30 Sep 2020
13F
MORGAN STANLEY
13F
Company
0.02%
23,277
$40,000 30 Sep 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.02%
23,139
$39,000 30 Sep 2020
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0.02%
20,385
$34,572 30 Sep 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
16,483
$101,000 30 Sep 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
16,210
$27,000 30 Sep 2020
13F
COMERICA BANK
13F
Company
0.01%
15,526
$35,000 30 Sep 2020
13F
LPL Financial LLC
13F
Company
0.01%
13,510
$23,000 30 Sep 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.01%
12,585
$21,000 30 Sep 2020
13F
Private Advisor Group, LLC
13F
Company
0.01%
10,736
$18,000 30 Sep 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.01%
10,590
$18,000 30 Sep 2020
13F
UNITED CAPITAL FINANCIAL ADVISORS, LLC
13F
Company
0.01%
10,500
$18,000 30 Sep 2020
13F
Crescent Grove Advisors, LLC
13F
Company
0.01%
10,000
$17,000 30 Sep 2020
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
9,649
$19,000 30 Sep 2020
13F
Cedar Mountain Advisors, LLC
13F
Company
0.01%
5,651
$10,000 30 Sep 2020
13F
IFP Advisors, Inc
13F
Company
0%
5,000
$8,000 30 Sep 2020
13F
TRUST CO OF VERMONT
13F
Company
0%
5,000
$8,000 30 Sep 2020
13F
Rockefeller Capital Management L.P.
13F
Company
0%
3,540
$5,000 30 Sep 2020
13F
CHIRON CAPITAL MANAGEMENT, LLC
13F
Company
0%
3,500
$6,000 30 Sep 2020
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
3,029
$6,000 30 Sep 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
2,000
$3,000 30 Sep 2020
13F
Cantonale Vaudoise Banque
13F
Individual
0%
1,368
$2,000 30 Sep 2020
13F
FIFTH THIRD BANCORP
13F
Company
0%
1,000
$2,000 30 Sep 2020
13F
NEXT Financial Group, Inc
13F
Company
0%
946
$2,000 30 Sep 2020
13F
Bank Julius Baer & Co. Ltd, Zurich
13F
Company
0%
750
$1,000 30 Sep 2020
13F
1832 Asset Management L.P.
13F
Company
0%
426
$1,000 30 Sep 2020
13F
TORONTO DOMINION BANK
13F
Company
0%
305
$1,000 30 Sep 2020
13F

Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q4 2020

As of 31 Dec 2020, ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by 30 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,085,633 shares. The largest 10 holders included Creative Planning, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA ADVISERS, LP, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, MARSHALL WACE, LLP, CIBC World Markets Inc., Marshall Wace North America L.P., MORGAN STANLEY, ROYAL BANK OF CANADA, and BANK OF AMERICA CORP /DE/. This page lists 30 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2020 vs Q3 2020 Across Filers

Q3 2020 holders
27
Q4 2020 holders
30
Holder diff
3
Investor Q3 2020 Shares Q4 2020 Shares Share Diff Share Chg % Q3 2020 Value $ Q4 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .